Proud of the new start of EV Biotech, an innovative resident of Campus Groningen. With a renewed vision and strategy, EV Biotech is ready to transform the future of biotechnology under the guidance of RUG Ventures.
EV Biotech was founded five years ago by Linda Dijkshoorn. The company focuses on developing and optimizing precision fermentation solutions. They use AI-driven strain engineering to design bacteria that can produce high-quality bio-based ingredients.
"With a strengthened team and a clear path to market, we are ready to take our expertise in strain development to the next level. Our AI-driven platform enables faster, smarter, and more reliable strain creation and optimization. We look forward to the exciting innovations ahead."
Linda Dijkshoorn, founder of EV Biotech
EV Biotech will focus on sharpening their focus, accelerating commercialization, and enhancing their capacity to bring precision fermentation solutions to market. Their expertise in AI-driven strain engineering allows them to turn biology into a scalable production platform for industries needing high-quality bio-based ingredients.
EV Biotech has also resumed its activities on the Zernike Campus.
Text: Campus Groningen
Image: own image EV Biotech/RUG Ventures
The Campus Trail at Campus Groningen is once again generating a lot of enthusiasm. So far, 500 participants have already registered for the seventh edition of the running event, which will take place on Friday, September 11.
It all started fourteen years ago with an idea in a laboratory on the Zernike Campus in Groningen. The financing has now been secured, and BioBTX can build a factory in Delfzijl.
UMCG is continuing the development of the new Central Laboratory for Diagnostics and Research (CLDR). Over the coming period, the preliminary design will be further developed into a final design, bringing the realization of the new laboratory building another step closer.